Corrigendum to “Golgi-customized Trojan horse nanodiamonds impair GLUT1 plasma membrane localization and inhibit tumor glycolysis [371 (2024) 338–350]”

IF 10.5 1区医学 Q1 CHEMISTRY, MULTIDISCIPLINARY

Journal of Controlled Release Pub Date : 2024-11-24 DOI:10.1016/j.jconrel.2024.11.040

Bei Kang , Haobo Wang , Huaqing Jing , Yunsheng Dou , Sona Krizkova , Zbynek Heger , Vojtech Adam , Nan Li

引用次数: 0

查看原文本刊更多论文

"高尔基体定制木马纳米金刚石损害 GLUT1 质膜定位并抑制肿瘤糖酵解 [371 (2024) 338-350]" 更正

作者对图 3E 中错误地显示了一张无关图像表示遗憾。作者还发现图 S8 中的一处错误。这两处错误都发生在图像格式处理过程中，不会影响手稿结论的正确性。下面是正确的图 3E 和图 S8：下载高清图片 (70KB)Download：下载全尺寸图片

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Controlled Release 医学-化学综合

CiteScore

18.50

自引率

5.60%

发文量

700

审稿时长

39 days

期刊介绍： The Journal of Controlled Release (JCR) proudly serves as the Official Journal of the Controlled Release Society and the Japan Society of Drug Delivery System. Dedicated to the broad field of delivery science and technology, JCR publishes high-quality research articles covering drug delivery systems and all facets of formulations. This includes the physicochemical and biological properties of drugs, design and characterization of dosage forms, release mechanisms, in vivo testing, and formulation research and development across pharmaceutical, diagnostic, agricultural, environmental, cosmetic, and food industries. Priority is given to manuscripts that contribute to the fundamental understanding of principles or demonstrate the advantages of novel technologies in terms of safety and efficacy over current clinical standards. JCR strives to be a leading platform for advancements in delivery science and technology.